Skip to main content
. 2020 Apr 7;26(13):1513–1524. doi: 10.3748/wjg.v26.i13.1513

Figure 3.

Figure 3

Representation of cumulative survival in patients treated with primary tumor surgery and metastases with peptide receptor radionuclide therapy (green) and patients treated only with peptide receptor radionuclide therapy (blue). A: For patients treated with primary tumor surgery, the probability of long-term survival is higher when treated with peptide receptor radionuclide therapy, showing the existence of a directly proportional relationship between survival and surgical treatment; B: The patients treated with metastases.